08 Mar 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Clinical supply chain solutions provider, Marken has built a new pharmaceutical depot in Beijing, China. The new facility provides 850 square meters of good manufacturing practices (GMP) compliant space for temperature controlled storage as well as distribution of clinical trial supplies.
It is situated next to the Beijing Capital International Airport and is co-located with the existing Marken Beijing branch office to provide a fully integrated and best in class service to clients.
The new depot will supplement Marken's existing network of global depots in Germany, Singapore, the US, Argentina, and Mexico. Marken's depot network is connected through the Solo platform, a global state-of-the-art, 21 CFR part 11 validated, cloud-based inventory management system, which tracks dosages at the patient level.
"We are very pleased to announce the completion of our new depot in China. We now have six fully operational depots in strategic areas globally and plan to open five additional depots before the end of 2013. Enlarging our network to provide the most efficient and flexible solutions to our clients is one of our key priorities for 2013," said Mr Gerit Offenhauser, senior vice president, Clinical Trials Distribution, Marken.
Mr Wes Wheeler, CEO, Marken, said that, "We are proud to expand our pharmaceutical service depot network to Beijing, China. We are now pushing forward with more depots in key countries around the world such as Brazil, Chile, Columbia and Russia. Through expanded investment in facilities and technologies, we will continue to ensure that our clients are provided with full service, global clinical supply chain solutions that provide the highest quality courier and logistics services to our clients."